Portola Pharmaceuticals Holdings is on the Cruelty Free Investing list for exploiting animals because the company does animal testing in developing and commercializing of some of their pharmaceutical products.
“The finding that andexanet alfa significantly reduced blood loss in an animal model of rivaroxaban bleeding while the PCC showed no reversal activity or improvement in bleeding is consistent with other animal model data from studies conducted by Portola and other labs,” said John T. Curnutte, M.D., Ph.D., executive vice president, research and development, for Portola”
Portola Pharmaceuticals, Inc. engages in the development and commercialization of novel therapeutics in the areas of thrombosis and other hematologic disorders, and inflammation. [Source: MarketWatch]
Company Website: https://www.portola.com/